CClinicalTrials.gg
CompletedNCT02836769HNC-RCUpdated Sep 17, 2021Results posted

Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer

An interventional study of Rehabilitation Consult (RC) in Head and Neck Neoplasms, sponsored by Sunnybrook Health Sciences Centre. Completed at 2 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-17.

Sponsored by Sunnybrook Health Sciences Centre · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Although evidence exists to support cancer rehabilitation, services are fragmented and rehabilitation professionals are consulted infrequently and often long after treatment ends, when chronicity of problems limits the impact of intervention. Therefore, the objective of this project is to develop, implement, and conduct a pilot evaluation of the Rehabilitation Consult (RC). The RC program goals are to increase knowledge about rehabilitation needs and resources to meet those needs; to establish individualized rehabilitation goals for HNC survivors and personalized action plans to meet those goals; and to provide support to HNC survivors for the implementation and evaluation of action plans. This project consisted of intervention development and pilot evaluation; this trial registration describes the pilot evaluation phase only.

Read the detailed description

A RC for survivors of head and neck cancer (HNC) was developed in collaboration with an Advisory Panel that includes survivors, family members, health care professionals, and health system representatives. This phase of the study aims to conduct a pilot evaluation of the RC using a mixed method, single group study with a convenience sample of approximately 35 survivors of HNC post primary cancer treatment, recruited from the Princess Margaret Cancer Center HNC clinics. In addition to the RC intervention, participants will be required to attend 3 research assessments (pre intervention, post intervention, and 1 month follow-up) that are a combination of face-to-face visits and telephone calls.

Quantitative data analysis will be exploratory and descriptive, and effect sizes will be calculated for all outcomes to help plan for a future, controlled trial. Means, standard deviations, and Cohen's d effect size will be calculated for normally distributed data. For non-normally distributed data, medians, ranges, and a nonparametric effect size r will be calculated. For qualitative analysis, all interviews will be audio recorded, transcribed verbatim, and analyzed using a two-phased, hybrid approach that is both deductive and inductive. Findings will be summarized and reported to the Advisory Panel, who will then make recommendations regarding any additional modifications to the RC. The research team will make final decisions about RC modifications and will finalize a version for future evaluation.

02

Conditions studied

  • Head and Neck Neoplasms

Keywords

  • Rehabilitation
  • Head and neck cancer
  • Quality of life
  • self-efficacy
03

In context

Head and Neck Neoplasms

2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.

This study's enrollment of 35 is below the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

Sunnybrook Health Sciences Centre is the lead sponsor of 566 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult survivors of HNC who have completed active treatment (surgery, radiation, chemotherapy or any combination thereof) within 1-18 months.

Exclusion criteria

Exclusion Criteria:

  • Lack of English fluency,
  • Cognitive impairment, or concurrent major degenerative conditions likely to cause functional deterioration, and
  • Known active cancer.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Rehabilitation Consult (RC)

    Pilot testing: single group pre-post design

    Behavioral: Rehabilitation Consult (RC)

Interventions

  • BehavioralRehabilitation Consult (RC)

    The RC was designed to foster key contributors to self management in the participants. The RC is administered by a rehabilitation professional and consists of an initial one-hour face-to-face consult and follow-up appointment(s) 2-12 weeks later, either telephone or face-to-face. The initial consult consists of orientation, consultation, goal-setting, teaching cognitive strategies, introduction to online resources/action planning/planning coping responses, review/implementation intentions/scheduling follow-up. The follow-up consists of a reminder, reorientation, checking of progress on goals and plans, re-planning as necessary, and discharge or scheduling of further follow-up as necessary.

06

What researchers measure

Primary outcomes

  1. Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N)

    Cancer-specific self-report measure of quality of life, higher scores indicate higher self-reported quality of life. Scores can range from 0 to 148. Changes in overall score as well as subsets will be evaluated for evidence of impact of intervention.

    Time frame: A) 1 week post-intervention, B) 1-2 months post intervention

  2. Change in Medical Outcome Short Form (36) Health Survey - (SF-36)

    Self-report quality of life questionnaire. Higher scores indicate a higher self-reported quality of life. The Physical Composite Score (PCS) and the Mental Composite Score (MCS) are reported. Scores range from 0 to 100 for each individual item on the scale. These scores are then converted into composite totals based on the scoring system provided with the outcome measure.

    Time frame: A) 1 week post-intervention, B) 1-2 months post intervention

Secondary outcomes

  1. Change in Goal Performance, Satisfaction, and Self-efficacy

    Participants completed the Brief Rehabilitation Assessment for Survivors Of Head And Neck Cancer (BRASH), a self report tool where participants rate their current performance, satisfaction with self-selected rehab goals, and rate their confidence in their ability to achieve each goal. Higher scores indicate greater self-reported, performance, satisfaction, and self-efficacy. Scores for each of confidence, performance, and satisfaction can range from 0 to 100. Each category is then compared to itself and the change calculated by subtracting the earlier score from the latter.

    Time frame: A) 1 week post-intervention, B) 1-2 months post intervention

07

Results

Posted Sep 17, 2021
Limitations and caveats
This study did not include a control group and it is not known whether the improvements are due to the intervention, time, or other factors. Results from a single hospital may not be generalizable to other head and neck populations.

Participant flow

Participant flow — Overall Study
MilestoneRehabilitation Consult (RC)
Started35
Received intervention30
Completed post-test assessment21
Completed20
Not completed15
Withdrew: Lost to follow-up10
Withdrew: Medical withdrawal2
Withdrew: Withdrawal by subject3

Outcome measures

PrimaryChange in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N)

Cancer-specific self-report measure of quality of life, higher scores indicate higher self-reported quality of life. Scores can range from 0 to 148. Changes in overall score as well as subsets will be evaluated for evidence of impact of intervention.

Time frame:
A) 1 week post-intervention, B) 1-2 months post intervention
Reported as:
Mean · score on a scale
Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N)
score on a scaleRehabilitation Consult (RC)
Mean difference (post - pre)3.1 ± 11.6
Mean difference (follow-up - pre)5.3 ± 12.3
PrimaryChange in Medical Outcome Short Form (36) Health Survey - (SF-36)

Self-report quality of life questionnaire. Higher scores indicate a higher self-reported quality of life. The Physical Composite Score (PCS) and the Mental Composite Score (MCS) are reported. Scores range from 0 to 100 for each individual item on the scale. These scores are then converted into composite totals based on the scoring system provided with the outcome measure.

Time frame:
A) 1 week post-intervention, B) 1-2 months post intervention
Reported as:
Mean · score on a scale
Change in Medical Outcome Short Form (36) Health Survey - (SF-36)
score on a scaleRehabilitation Consult (RC)
PCS - Mean difference (post - pre)3.5 ± 7.6
PCS - Mean Difference (follow-up - pre)6.7 ± 8.0
MCS - Mean difference (post - pre)4.3 ± 9.5
MCS - Mean Difference (follow-up - pre)2.8 ± 7.7
SecondaryChange in Goal Performance, Satisfaction, and Self-efficacy

Participants completed the Brief Rehabilitation Assessment for Survivors Of Head And Neck Cancer (BRASH), a self report tool where participants rate their current performance, satisfaction with self-selected rehab goals, and rate their confidence in their ability to achieve each goal. Higher scores indicate greater self-reported, performance, satisfaction, and self-efficacy. Scores for each of confidence, performance, and satisfaction can range from 0 to 100. Each category is then compared to itself and the change calculated by subtracting the earlier score from the latter.

Time frame:
A) 1 week post-intervention, B) 1-2 months post intervention
Reported as:
Mean · score on a scale
Change in Goal Performance, Satisfaction, and Self-efficacy
score on a scaleRehabilitation Consult (RC)
Performance (post - pre)16.6 ± 32.3
Performance (follow-up - pre)37.3 ± 31.2
Satisfaction (post - pre)26.9 ± 35.4
Satisfaction (follow-up- pre)39.2 ± 32.6
Self-efficacy (post - pre)18.4 ± 27.1
Self-efficacy (follow-up- pre)17.1 ± 35.8

Adverse events

Collected over Adverse event data were collected during the 15 months when study participants were enrolled.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Rehabilitation Consult (RC)0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Rehabilitation Consult (RC)
Mean59.8 ± 13
Sex: Female, Male
Sex: Female, Male(Participants)Rehabilitation Consult (RC)
Female7
Male28
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Rehabilitation Consult (RC)
Weeks post-treatment
Weeks post-treatment(weeks)Rehabilitation Consult (RC)
Mean38.2 ± 22
Had rehab goals
Had rehab goals(Participants)Rehabilitation Consult (RC)
Count of participants23
08

Study locations

2 sites
  • Sunnybrook Health Sciences Centre, Odette Cancer Centre
    Toronto, Ontario M4N 3M5, Canada
  • University Health Network, Princess Margaret Cancer Centre
    Toronto, Ontario M5G 2M9, Canada
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 11, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02836769
Lead sponsor
Sunnybrook Health Sciences Centre
Collaborators
Princess Margaret Hospital, Canada, Toronto General Hospital, University Health Network, Toronto
Responsible party
Sponsor
First posted
Jul 19, 2016
Start date
Jan 2016
Primary completion
Dec 2017
Completion
May 2018
Results posted
Sep 17, 2021
Last update
Sep 17, 2021

Study contacts

Sara McEwen, PhD
principal investigator · Sunnybrook Research Institute, St. John's Rehab Program

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion